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ABSTRACT
This study was conducted within the European SHIPSAN (ship sanitation) project and aims at
exploring the legislative framework and current practices related to surveillance of communi-
cable diseases and response aboard passenger ships in Europe. A detailed questionnaire was
disseminated and completed by 59 competent authorities in 27 European countries. The
majority of competent authorities used national legislation without special provisions for pas-
senger ships. Only 20% had specific provisions for ships regarding quarantine, while a smaller
proportion of new Member States (MS) have specific legislation in comparison with old MS
(p = 0.01). The Maritime Declaration of Health (MDH) was the main reporting tool used. About
30.5% of the competent authorities declared that they require submission of MDH by all arri-
ving ships, but 28.8% only from affected areas, and 11.9% never require MDH. A total of 45
outbreaks or incidents (36 gastrointestinal, 1 incident of legionellosis, 3 respiratory, and
1 influenza-like illness outbreak, occupational tuberculosis, varicella, scabies, and meningitis)
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were reported to EU competent authorities during 2006. About 75% of the responders stated
that there are gaps in the surveillance and control of communicable diseases. A diversity of
approaches in EU countries, and gaps regarding surveillance and response and training needs
of personnel were identified.
(Int Marit Health 2011; 62, 2: 138–147)
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tion of measures for the prevention and control of
communicable diseases on ships.
The International Health Regulations (IHR) 2005
require strengthening of countries’ surveillance ca-
pacities and include specific provisions for ship-to-
port reporting of diseases and port-to-port informa-
tion sharing.
The European Parliament and Council Regulation
851/2004 established a European Centre for Disease
Prevention and Control (ECDC) that is responsible for
the surveillance of infectious diseases at a European
level. ECDC has established an EU-wide standard case
reporting system and maintains the databases for epi-
demiological surveillance. All 27 EU MS and three Eu-
ropean Economic Area countries report their available
data on communicable diseases to the ECDC [11] us-
ing standard case definitions of 46 diseases (listed in
the Decisions 2002/253/EC and 2003/534/EC) plus
SARS, West Nile Fever, and Avian Influenza. ECDC
operates the European Surveillance System (TESSy)
for the collection, validation, cleaning, analysis, and
dissemination of data. Moreover, ECDC monitors trends
of diseases across Europe and coordinates the opera-
tion of dedicated surveillance networks. ECDC’s Pre-
paredness and Response Unit monitors emerging
threats in Europe and internationally, and supports
the EU Member States in assessing, investigating, and
responding to them. The Unit relies on a set of ad-
vanced information technology tools to detect poten-
tial threats, with special attention paid to events threa-
tening more than one EU Member State. The assess-
ment of such threats is done jointly with experts from
the EU Member States.
In 2002, the European Parliament and the Coun-
cil adopted a Decision establishing a programme of
Community action in the field of public health (2003–
–2008). One of the general objectives of this pro-
gramme was to enhance the capability of respon-
ding rapidly and in a coordinated fashion to health-
-related threats. In 2006, the European project
SHIPSAN was funded by the Directorate General for
Health and Consumers of the European Commission
INTRODUCTION
As on land, cases or outbreaks of communicable
diseases can occur during travelling on board pas-
senger ships including ferries and cruise ships. In re-
cent years outbreaks of communicable disease such
as influenza [1], gastroenteritis [2], and Legionnaires’
disease [3, 4] have been reported on ships sailing in
Europe. The results of a literature review showed that
from 1970 through June 2003 there were a total of
21 reported waterborne outbreaks [5], 50 foodborne
outbreaks [6], and 51 incidents of Legionnaires’ di-
sease, associated with ships of all types [7]. From 1997
to 2006, 9 confirmed outbreaks of influenza occur-
ring on ships were published in the scientific litera-
ture. Between 1 January and 5 July 2006, 42 repor-
ted outbreaks of gastroenteritis on 13 different cruise
ships sailing in European waters were confirmed or
suspected to be caused by norovirus [8].
During 2009 there were 188 cruise ships sailing
in Europe with a capacity of 203,600 cabins, gene-
rating 23.8 million passenger visits to European port
cities. The European cruise market grew by 41% from
2006 to 2009 and more than doubled over the last
10 years [9]. Approximately 320 million passengers
ferry trips were recorded through European ports in
2007 [10]. An increasing proportion of the Europe-
an population travels in modern ships, which are
becoming more complex and which are designed to
carry many more passengers and crew. Passenger
ships have public health importance since the semi-
closed environment favours person-to-person trans-
mission of pathogens. Moreover, travellers share com-
mon food and water, and potential contamination can
cause waterborne and foodborne disease outbreaks.
Finally, passenger ships could contribute to transna-
tional transmission of communicable diseases.
Systematic collection of data related to infectious
diseases on board passenger ships and reporting of
diseases to competent authorities is important for both
shipping companies and competent authorities at
ports. Competent authorities are public health agen-
cies responsible for the implementation and applica-
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in order to address such ship-related health issues
(www.shipsan.eu). ECDC was a collaborative partner
of the SHIPSAN project and played a key advisory
role during its implementation. The main objective of
the EU SHIPSAN project was to assess the useful-
ness of an integrated common programme for com-
municable diseases surveillance and hygiene inspec-
tions in Europe. The aim of this study was to describe
the current situation regarding the surveillance prac-
tices of the authorities and relevant legislation in
competent authorities of 30 EU MS and European
Free Trade Association (EFTA) countries responsible
for detection, surveillance, and response to commu-
nicable diseases related to ships.
MATERIAL AND METHODS
DATA COLLECTION
The data collection process was implemented in
two phases and lasted from August 2007 until Feb-
ruary 2008. During the first phase, a questionnaire
was disseminated to the Ministry of Health or Public
Health Institute of each country. The questionnaire
asked for contact details of competent authorities
having the responsibility for communicable disease
surveillance and response related to ships at a na-
tional or local level in each country. The recipient
and person responsible for completing the question-
naire was the director of the authority. Follow up e-
-mails were sent and telephone communications were
conducted to ensure correct completion of question-
naires. Contact details for 61 national and regional
competent authorities were identified in 30 EU MS
and EFTA countries: Austria, Belgium, Bulgaria, Croa-
tia, Cyprus, the Czech Republic, Denmark, Estonia,
Finland, France, Germany, Greece, Hungary, Iceland,
Ireland, Italy, Latvia, Lithuania, Malta, Norway, Poland,
Portugal, Romania, Slovakia, Slovenia, Spain, Swe-
den, the Netherlands, Turkey, and the United King-
dom. Luxembourg and FYROM were not relevant to
this study since they do not receive visits from in-
land or sea-going passenger ships.
In the second phase of the data collection pro-
cess, a questionnaire was constructed, pilot tested,
and disseminated to the competent authorities which
were identified during the first phase. The pilot tes-
ting of the questionnaire was conducted by site vi-
sits in one small (Malta) and in one large country
(Germany). In these site visits all the competent au-
thorities were visited and a meeting with the direc-
tor was arranged to fill in the questionnaire. This
questionnaire was used to collect data on legisla-
tion and practices for the surveillance of communi-
cable diseases related to passenger ships: i) legisla-
tion related to quarantine of humans or animals,
surveillance, control, outbreak detection, and inves-
tigation of communicable diseases, and guidelines
to control specific communicable diseases (e.g. no-
rovirus, Legionella), ii) diseases required to be re-
ported by ships, iii) provision of specific outbreak
definition on ships, iv) number of cases or outbreaks
reported by ships during 2006, v) requirements for
issuance of an order to not sail, vi) policy related to
the IHR Maritime Declaration of Health submission,
vii) collection of information related to travel on pas-
senger ships within the routine surveillance system,
and viii) training needs and gaps regarding know-
ledge on communicable disease surveillance rela-
ted to passenger ships. To facilitate the data collec-
tion process, site visits were organised to compe-
tent authorities of countries belonging mainly to
groups A and B. Since the questionnaire was draf-
ted in English, translations were asked for by three
competent authorities in Greece, Italy, and Roma-
nia. Follow up e-mails were sent and telephone com-
munications were conducted to ensure correct com-
pletion of questionnaires.
DATA ANALYSIS
The data collected were entered into a specifically
designed database using EPI Info version 3.01, and
descriptive and correlation analyses were conducted.
Chi-square or Fischer exact tests were used to com-
pare qualitative variables. Results were considered
statistically significant when the P value was < 0.05.
EU countries were divided into four priority groups
(group A, B, C, and D) depending on the number of
passenger ships sailing in their country, volume of
passenger visits, and number of ports. The following
countries were included in group A (having a higher
number of passenger movements, ships, and ports
than groups B, C, and D): Denmark, France, Germa-
ny, Greece, Italy, Spain, Sweden, and the United King-
dom. Group B (having a higher number of passen-
ger movements, ships, and ports than groups C and
D): Belgium, Croatia, Estonia, Finland, Ireland, the
Netherlands, Norway, Poland, and Portugal. Group C
(having a higher number of passenger movements,
ships, and ports than group D): Bulgaria, Cyprus,
Latvia, Lithuania, Malta, Iceland, Romania, and Slo-
venia. The countries in Group D (having a lower num-
ber of passenger movements, ships, and ports than
groups A, B, and C) were Austria, the Czech Repu-
blic, Hungary, and Slovakia.
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Additionally, EU countries were categorised as old
or new MS. The old ones consist of Austria, Belgium,
Denmark, Finland, France, Germany, Greece, Iceland,
Ireland, Italy, Norway, Portugal, the Netherlands, Spain,
Sweden, and the United Kingdom. The new ones
(those counties that joined the EU in 2004 or later)
consist of Bulgaria, Cyprus, the Czech Republic, Esto-
nia, Hungary, Latvia, Lithuania, Malta, Poland, Roma-
nia, Slovakia, Slovenia, and Croatia. The data were
analysed according to groups A, B, C, and D and old
and new EU MS. The results from groups A and B
(merged into one group) were compared to the re-
sults from groups C and D (merged into one group).
RESULTS
COMPETENT AUTHORITIES IN THE EU
In the EU MS and the EFTA countries, the type of
competent authorities responsible for communica-
ble disease surveillance on ships and response dif-
fer from country to country. In particular, the compe-
tent authorities may include: a) ministries of health,
b) national surveillance centres or institutes of pub-
lic health; c) regional authorities for public health
and inspections; d) ministries of transport; e) food
and veterinary services; f) public health or epidemio-
logical units within municipalities; and g) port health
authorities. In some ports, authorities responsible for
occupational health, communicable disease surveil-
lance, and environmental health have been merged
into one authority. Analytical results of this study
containing the types of authorities and contact de-
tails can be found at the SHIPSAN project website
(www.shipsan.eu).
There were 59 completed questionnaires collec-
ted out of a total of 61 sent questionnaires related to
communicable disease surveillance in passenger ships
(response rate 96.7%) from 27 countries. In this study,
there are no data by competent authorities in Bel-
gium, Romania, and Turkey. Thirty-six were national
authorities and 23 were regional authorities.
Not all questions were answered by the 59 com-
petent authorities. Thus, the percentages were cal-
culated using the number of authorities that an-
swered the specific question as the denominator (ex-
cluding the missing values).
LEGISLATION RELATED TO COMMUNICABLE
DISEASES
The majority of competent authorities used na-
tional legislation without special provisions for pas-
senger ships regarding quarantine of humans or
animals (74.6%), surveillance and control of commu-
nicable diseases (81.4%), detection and investigation
of outbreaks (83.1%), and guidelines for the control
of specific communicable diseases (77.2%). Specific
legislation for passenger ships regarding the above-
mentioned issues was in place at a maximum by up
to 5 authorities in Iceland, Italy and, the Czech Re-
public out of the 59 authorities (Table 1).
REPORTING, SURVEILLANCE, AND OUTBREAK
INVESTIGATION OF COMMUNICABLE DISEASES
About 63% of authorities declared that ships on
international voyages were reporting diseases under
the IHR, while about 54% of the authorities declared
that ships on national voyages were reporting diseases
according to national legislation (Table 2).
Table 1.  Legislation for communicable disease surveillance and outbreak investigation applied by competent authorities (the
data collection process lasted from August 2007 until February 2008)
Subject of legislation                    Number of authorities that applied legislation
Specific for National with National without
passenger ships  provisions for provisions for Other*
passenger ships passenger ships
Yes/Total (%) Yes/Total (%) Yes/Total (%) Yes/Total (%)
Quarantine of humans or animals 5/59 (8.5) 7/59 (11.9) 44/59 (74.6) 5/59 (8.5)
Surveillance and control 3/59 (5.1) 6/59 (10.2) 48/59 (81.4) 2/59 (3.4)
of communicable diseases
Outbreak detection and investigation 3/59 (5.1) 5/59 (8.5) 49/59 (83.1) 3/59 (5.1)
of communicable diseases
Control of specific communicable 2/57 (3.5) 4/57 (7) 44/57 (77.2) 7/57 (12.3)
diseases (e.g. norovirus, Legionella)
*Guidelines based on best practice
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Eighteen out of 59 (30.5%) authorities declared
that they require submission of a Maritime Declara-
tion of Health (MDH) by all arriving ships, and about
28% of the authorities require submission by ships
arriving from affected areas or by ships in which
a communicable disease or death has occurred.
About 12% of the responding authorities stated that
it was not clear when submission of the MDH was
required with the new IHR (Table 3).
A total of 36 gastrointestinal outbreaks on board
passenger ships (three attributed to norovirus, one
to Campylobacter, and five to Salmonella) were re-
ported to competent European authorities during
2006 according to the completed questionnaires
collected. Furthermore, one incident of legionellosis,
three respiratory, and one influenza-like illness out-
break were also reported. Other diseases that were
reported included occupational tuberculosis, varicel-
la, scabies, and meningitis.
Thirty-three authorities out of the 53 (62.2%) de-
clared that they did not receive any outbreak report
on passenger ships during 2006. Twelve authorities
out of 53 (22.6%) declared that they received one
outbreak report. Seven authorities reported an ave-
rage of two to five outbreaks, and only one authority
reported eight outbreaks.
About 7% of the responding authorities never in-
vestigated outbreaks on ships, while about 51% of
the authorities investigated every outbreak reported
on ships. Specific criteria for outbreak investigation
of ships on international and national voyages had
been used by about 24% and 27% of the authorities,
respectively (Table 4).
About 57% of the authorities (32 out of 56) de-
clared that they collect information related to travel
with passenger ships in their routine surveillance sys-
tems or in the routine case investigation procedure.
No authority declared providing a specific out-
break definition different from that for community
outbreaks. About 59% of the authorities (32 out of
54) had specific criteria to issue an order that a ship
cannot sail.
TRAINING ON SURVEILLANCE AND CONTROL
OF COMMUNICABLE DISEASES
The personnel of 38 authorities had received
training on surveillance and outbreak investigation
within the last three years. About 67% of the na-
tional authorities (21 out of 32) and 74% (17 out of
23) of regional departments declared that they had
received training. The personnel of only two out of
54 (3.7%) responding authorities from Hungary and
Table 2. Communicable disease reporting in 59 competent authorities (the data collection process lasted from August 2007
until February 2008)
Subject area                                                     Number of authorities (%)
Ships on international travel Ships on national travel
IHR diseases 37 (62.7) 29 (49.2)
Diseases reported to competent All notifiable 25 (42.4) 32 (54.2)
Voluntary basis 16 (27.1) 15 (25.4)
Other** 4 (6.8) 4 (6.8)
*More than one answer was applicable; **authorities provided the titles of national legislation
authority by ships*
Table 3. Submission of Maritime Declaration of Health in 59 competent authorities (the data collection process lasted from
August 2007 until February 2008)
Occasions of submission of the MDH                                                Number of authorities (%)
Previous IHR IHR 2005
Not required 3 (5.1) 7 (11.9)
All ships 25 (42.4) 18 (30.5)
Ships arriving from affected areas 20 (33.9) 17 (28.8)
Ships on which communicable disease or death has occurred 21 (35.6) 16 (27.1)
Don’t know – 7 (11.9)
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Portugal had received training specifically for in-
vestigations on ship. Thirty-five of the 54 respond-
ing authorities (64.8%) believed that specific trai-
ning for surveillance and outbreak investigation on
passenger ships is needed.
The subject areas that the competent authorities
identified in which specific training should be re-
quired: routine surveillance, knowledge of special
conditions aboard ships, legislation (international and
national), environmental health control measures,
outbreak investigation and management, methodol-
ogy of epidemiological studies and presentation of
findings, methods for data validation and their cha-
racteristics related to time, case management of an
infectious disease (referral, transportation means),
and finally information on IHR 2005 and the capa-
bility to implement present and future World Health
Organisation guidelines.
GAPS IN SURVEILLANCE AND RESPONSE
Forty-two of the 56 (75%) responders stated that
they believe there are gaps in the surveillance and
control of communicable diseases related to ships.
The issues reported by the competent authorities
included: a) data collected by the local authorities
at ports were not sent to the national authorities;
b) lack of specific surveillance related to passen-
ger ships; c) overlapping of responsibilities among
different competent authorities within the same
country; d) lack of communication between public
health authorities within the same country and
between different countries; e) underreporting of
communicable diseases and outbreaks; f) lack of
specific training in communicable disease surveil-
lance and outbreak management; and g) lack of
resources.
COMPARISON AMONG THE FOUR
CATEGORIES OF GROUPED COUNTRIES
AND OLD AND NEW EU MS
Surveillance practices, which statistically signifi-
cantly differed among the four categories of grouped
countries, and old and new MS (those counties that
joined the EU in 2004 or later), are presented in Ta-
ble 5 and Table 6, respectively. Statistical significant
differences were found among the categories of
grouped countries regarding reporting requirements,
outbreak investigation on ships on national and in-
ternational voyages, and gaps reported in training
and surveillance related to ships (Table 5).
A higher percentage of new EU MS (21 out of the
23 authorities, 91.3%) in comparison to old EU MS
(23 out of the 36 authorities, 63.9%) declared that
they apply national legislation or regulations or guide-
lines on quarantine of humans or animals without
provisions for passenger ships (p = 0.01). Further-
more, from the 16 authorities receiving reports on
a voluntary basis from ships on an international vo-
yage, only two authorities from Croatia belong to the
new EU MS (2 out of 23, 8.7%), whereas all 15 au-
thorities receiving reports on a voluntary basis from
ships on a national voyage belong to the old EU MS.
From the new EU MS, 13 out of 22 (59.1%) declared
that there are gaps whereas from the old MS, 29 of
34 (85.3%) stated there are gaps in surveillance and
control of communicable disease practices and le-
gislation. Investigation of outbreaks on ships on in-
ternational voyages was more common among au-
thorities belonging to groups A and B (36 out of 59
authorities) in comparison to authorities belonging to
groups C and D (19 out of 59 authorities), p = 0.01.
The results were similar regarding the investigation
of outbreaks of ships on national voyages (4 author-
Table 4. Outbreak investigation practices in 59 competent authorities (the data collection process lasted from August 2007
until February 2008)
Subject area                                                        Number of authorities (%)
         Ships on international travel    Ships on national travel
Never investigated outbreaks 4 (6.8) 4 (6.8)
Investigated every outbreak 30 (50.8) 30 (50.8)
Outbreak investigation According to specific criteria 8 (13.6) 11 (18.6)
(severity, attack rate, etc.)
After requested by the ship’s master 14 (23.7) 16 (27.1)
After passenger complaints 12 (20.3) 15 (25.4)
Other* 12 (20.3) 12 (20.3)
*After requested by public health authorities in charge
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ities belonging to groups C and D had never investi-
gated an outbreak on a ship on a national voyage,
p = 0.01). A total of 11 authorities belonging to groups
A and B investigate outbreaks according to specific
criteria, while no authority from groups C and D use
such criteria (p = 0.002).
DISCUSSION
This study identified a diversity of approaches in
EU countries, and gaps in surveillance and training
needs of personnel. Only a few countries enforced
specific legislation for ships, while the majority of them
use national legislation applied on land. One impor-
tant finding of our study is that a small proportion of
new EU MS have specific legislation or provisions for
ships, while at the same time the frequency of re-
ported gaps is lower than those reported by the old
EU MS. Thus we can assume that the new MS do not
have, to the same priority, the surveillance and con-
trol of communicable diseases on board passenger
ships. Investigations of outbreaks on ships on inter-
national voyages were more common among coun-
tries belonging to groups A and B having higher
maritime traffic and more experience in outbreak
response, in comparison to countries belonging to
groups C and D. Counties belonging to groups A and
B seem to have a more standardized approach re-
garding response to reported outbreaks, since they
use specific criteria when deciding to respond and
conduct outbreak investigations. These findings also
show the diversity of experience among personnel
of public health authorities.
Surveillance on board passenger ships seems to
be an easy task, especially on ships with a doctor on
board. The reference population on board (crew and
passengers) is known on a daily basis. Moreover, ill
persons can refer to medical staff on board making
the data collection easy. Passengers and crew, when
on board, can be contacted at any time, and there-
fore surveillance data can be accurate and complete.
On the other hand, passengers may avoid visiting
the doctor, especially for relatively mild diseases (gas-
trointestinal or respiratory) for economical reasons
or because they are afraid of possible isolation. Ho-
Table 5. Results of correlation analysis regarding surveillance practices in four different priority country-groups
Surveillance practices Group A Group B Group C Group D P value
Yes/Total (%) Yes/Total (%) Yes/Total (%) Yes/Total (%)
Every ship on an international voyage 10/21 (47.6) 1/15 (6.7) 9/16 (56.3) 5/7 (71.4) 0 .008
is required to report all notifiable
diseases for humans or animals as
defined in national laws for
epidemiological surveillance
Ships report diseases or outbreaks on 12/21 (57.1) 4/15 (26.7) 0/16 (0) 0/7 (0) 0 .0004
a voluntary basis on an international
voyage
Every ship on a national voyage is 11/21 (52.4) 4/15 (26.7) 12/16 (75) 5/7 (71.4) 0 .04
required to report all notifiable diseases
for humans or animals as defined in national
laws for epidemiological surveillance
Ships report diseases or outbreaks on 12/21 (57.1) 3/15 (20) 0/16 (0) 0/7 (0) 0 .0002
a voluntary basis on an international voyage
Never investigated outbreaks on ships on 0/21 (0) 0/15 (0) 1/16 (6.3) 3/7 (42.9) 0.0007
an international voyage
Never investigated outbreaks on ships 0/21 (0) 0/15 (0) 1/16 (6.3) 3/7 (42.9) 0.0007
on a national voyage
Investigation of every outbreak 7/21 (33.3) 8/15 (53.3) 13/16 (81.3) 2/7 (28.6) 0 .019
Investigation of outbreaks according 7/21 (33.3) 4/15 (26.7) 0/16 (0) 0/7 (0) 0 .030
to specific criteria
Specific training on surveillance and 13/21 (61.9) 6/11 (54.5) 15/16 (93.8) 1/6 (16.7) 0.0057
outbreak investigation for ships is needed
Gaps in the surveillance and control of 18/21 (85.7) 12/13 (92.3) 11/16 (68.8) 1/6 (16.7) 0 .0022
communicable diseases on board
cruise ships and ferries
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wever, laboratory confirmation of a diagnosis is not
always possible since there are not many reliable
microbiological examination methods that can be
conducted on board or in due time on land. There-
fore, surveillance of diseases may be more feasible if
it is based on syndromes. Moreover, some of the com-
municable diseases with a long incubation period
can be diagnosed after disembarkation and could
be collected through the national surveillance sys-
tems and related to travelling with passenger ships
afterwards.
Improved surveillance on board as well as national
and international outbreak surveillance has been
highly emphasised by many authors, investigators,
and organisations [1, 12–17]. Maintenance of me-
dical logs and the active monitoring of illness on board
allows ships to detect outbreaks and other untoward
communicable disease events early to enable timely
application of preventive measures. Ships that con-
duct enhanced surveillance are able to collect base-
line information on communicable diseases by sea-
son and specific itineraries, to determine thresholds
for outbreak detection and evaluate and decide ad-
ditional control measures.
Ships report diseases to competent authorities at
ports according to international and national legisla-
tion. If an infection has occurred on board a ship on
an international voyage, the master is required to
report it to the competent authority of the next port
of call according to the IHR [18]. Subsequently, if an
outbreak is suspected, the competent authority staff
may wish to see the ship’s surveillance data whilst
undertaking a risk assessment. If they consider that
there is a risk of transmission of the infection in their
country or other MS, they may alert their national
surveillance centre and/or national focal point. It is
important, therefore, that good surveillance logs are
maintained by the ship.
Collection of surveillance data by competent au-
thorities from passenger ships sailing in European
waters can improve the evidence base for preven-
tive actions taken in the control of outbreaks on pas-
senger ships. It can help authorities in case investi-
gation, management, and follow up. It can also be of
benefit for authorities when assessing the risks from
communicable diseases and public health events
and evaluating preventive actions. Finally, the sur-
veillance data can help EU and international systems
Table 6. Results of correlation analysis regarding surveillance practices in old and new EU MS
Surveillance practices New EU MS Old EU P value
Yes/Total (%) Yes/Total (%)
National Legislation or regulations or guidelines 21/23 (91.3) 23/36 (63.9) 0.01
without provisions for cruise ships and ferries on
an international voyage
National Legislation or regulations or guidelines 22/23 (95.7) 27/36 (75) 0.038
without provisions for cruise ships and ferries on
a national voyage
Ships reported diseases or outbreaks on a voluntary 2/23 (8.7) 14/36 (38.9) 0.009
basis on an international voyage
Every ship on a national voyage was required to report 16/23 (69.6) 16/36 (44.4) 0.05
all notifiable diseases for humans or animals as defined
in national laws for epidemiological surveillance
Ships reported diseases or outbreaks on a voluntary 0/23 (0) 15/36 (41.7) 0.0001
basis on a national voyage
Authorities never investigated outbreaks on ships on 4/23 (17.4) 0/36 (0) 0.019
an international voyage
Authorities never investigated outbreaks on ships 0/36 (0) 4/23 (17.4) 0.019
on a national voyage
Authorities investigated every outbreak 17/23 (73.9) 13/36 (36.1) 0.004
Submission of the Maritime Declaration of Health is not 5/23 (21.7) 2/36 (5.6) 0.073
required by any arriving ship
Gaps in the surveillance and control of communicable 13/22 (59.1) 29/34 (85.3) 0.029
diseases
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in early detection and response and to assist in con-
tact tracing.
Our study results show that underreporting of
diseases may occur, since almost 62% of the respon-
ding authorities declared zero outbreaks for the year
2006. A total of 36 gastrointestinal outbreaks (3 no-
rovirus, 6 bacterial, and 27 of unknown pathogen)
were reported by the competent authorities which
participated in our study. According to the literature,
between 1 January and 5 July 2006, 42 reported
outbreaks of gastroenteritis on 13 different cruise
ships sailing in European waters were confirmed or
suspected to be caused by norovirus [8]. In the same
year, 35 outbreaks of norovirus gastroenteritis,
4 unknown, and 1 due to E. coli were reported in the
Centres for Diseases Control and Prevention, Vessel
Sanitation Programme in the US (www.cdc.gov/nceh/
/vsp/surv/GIlist.htm#2006).
Among the reported gaps was the failure of local
authorities to report data that are collected by ships
to competent regional authorities or at a national le-
vel. Enhanced communication of data received by
competent authorities at ports at a national level is
needed.
Underreporting may be also attributed to the lack
of knowledge of reporting requirements by the ship
personnel. Even if the ship reports to the local au-
thority, in many cases there is an absence of a de-
tailed investigation and it is therefore difficult to iden-
tify the possible cause or hygiene deficiencies re-
lated to the incident. The length of stay on passenger
ships ranges from a few hours for ferries to one or
more weeks for cruise ships. The limited time peri-
od on board decreases the possibility of retrospec-
tively linking the travel with the disease. A passen-
ger may have left the ship before symptoms begin
or become serious enough to warrant medical at-
tention. Diseases diagnosed after the disembarka-
tion of a passenger are difficult to link to a specific
ship unless case investigation forms include que-
ries about previous travel of the patient by ship.
Furthermore, offshore activities contributing to di-
sease may become evident during a cruise [19], while
passengers might be exposed to sources of infec-
tion such as hotels before or after the cruise. It can
therefore become difficult to clearly identify the ship
as the source of an infection [4]. Exclusively ship-
-related infectious diseases are, therefore, proba-
bly underestimated [19]. However, in some instanc-
es they are overestimated in comparison with land-
based premises when an enhanced, specific surveil-
lance system is in place such as the gastrointestinal/
/norovirus surveillance conducted by the US CDC
Vessel Sanitation Programme.
Since priority country group A is the group with
the highest number of ports, passenger ships, and
number of passengers, a more effective outbreak
investigation routine would have been expected. In
addition, almost 24% of the authorities belonging to
group A investigate outbreaks when requested by
the ship company. Only 33.3% and 27.7% of the au-
thorities from priority groups A and B, respectively,
investigate outbreaks with specific criteria for inter-
national and national voyages.
Training needs on the surveillance and control of
communicable diseases specifically for ships were
reported by the majority of the authorities which par-
ticipated in our study. Regular training courses could
be organised on a regional, national, or international
level. Special training seems to be needed for the
application of the IHR and the requirement of the
MDH. The WHO organises training courses, and train-
ing using electronic means is also provided
(www.who.int).
Our study results showed a diversity of approa-
ches regarding response to outbreaks. When an out-
break occurs on a ship sailing in Europe it is often
possible that more than one port authority within
a country or more than one country may be involved
in the investigation and outbreak management. Com-
munication regarding health measures implement-
ed, inspection findings, and investigation results is
needed. Coordination of actions so as to avoid dupli-
cation is also necessary. When more than one coun-
try is involved European level coordination is nee-
ded. All EU MS have procedures and tools in place
to monitor and assess early threats detected through
event-based surveillance and by using the ECDC
Threat Tracking Tool (TTT) to perform joint risk as-
sessment in the event that a threat is potentially af-
fecting more than one EU MS. If an outbreak on
a ship is considered to be a threat affecting the EU,
this should be reported through the web-based Ear-
ly Warning and Response System (EWRS). Through
the EWRS, the information is sent to the country of
the next port of call using routes at a national level.
Our study revealed useful information for the si-
tuation in Europe regarding surveillance and con-
trol of communicable disease related to ships. These
results could be valuable for competent authorities,
policy makers, and the shipping industry. Improved
surveillance is needed since underreporting of in-
fectious diseases from ships to ports could be sus-
pected, as well as training of personnel.
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